Nevertheless, patients with higher CHRNA7 expression in resected pancreatic tumors had better survival compared to those with a lower level of expression (HR = 0.51, 95% CI = 0.26–0.99; 5-year survival 18% vs. 0%; Figure 1C). Here, CHRNA7 is linked to pancreatic neoplasm.